ADHD – medicalising normal is an impressive business model
The new England-wide NHS prescription data* covering the month of September 2022 came out recently, presenting three full quarters of data. So it is time, once again, to scrutinise the data and see if, maybe, just once – fingers crossed – prescriptions will show a declining trend. Based on previous prescribing trends,…
